Author: McIlleron, Helen
Similar Items: Optimization of 1st-line antituberculosis dosing regimens using a population pharmacokinetic approach: food effects, drug combinations and pharmacological effects
- Preclinical pharmacokinetic evaluation of novel antimalarial and antituberculosis drug leads
- The pharmacokinetics and toxicity of antituberculosis agents and other co-administered drugs in children with tuberculosis, with and without HIV infection, and their relationship to nutritional status
- Repurposing chlorpromazine and its metabolites for antituberculosis drug discovery
- Pharmacokinetics and safety of first -- and second--line anti-- tuberculosis drugs in children
- Public Health Impact and Cost-Effectiveness of 2-Dose vs 1-Dose Human Papillomavirus Vaccination Regimen in Saudi Arabia
- A zebrafish larval model for drug-induced hepatic Injury due to first-line antituberculosis drugs and possible prevention/treatment with N-acetyl-cysteine